Literature DB >> 6160732

Blood-brain barrier selectivity and synaptic turnover during delirium tremens and related clinical states. A study of brain and blood proteins in the cerebrospinal fluid.

O S Jørgensen, R Hemmingsen, P Kramp, O J Rafaelsen.   

Abstract

The synaptic membrane protein D2 was measured in the cerebrospinal fluid (CSF) from patients with delirium tremens and related clinical states immediately after admission to the hospital before treatment was initiated and again after recovery. during this period of on average 5 days duration the concentration of D2 increased to double normal value possible indicating increased breakdown of old synapses during the process of readaptation to the alcohol free state. IgG, albumin and alpha 2-macroglobulin were measured in plasma and in CSF and the results indicated a decreased selectivity of blood-CSF-barrier permeability to proteins in the clinically recovered patients; this was probably due to increased micropinocytotic activity also occurring during readaptation to the alcohol free state.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160732     DOI: 10.1111/j.1600-0447.1980.tb00587.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

Review 1.  Cerebrospinal fluid markers in neurological disorders.

Authors:  A R Massaro; G Scivoletto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1990-12

2.  Iopamidol 300-induced epilepsy: intensive treatment and pathogenic hypothesis.

Authors:  E Carchietti; M Baldassarre; T Penco; M Leonardi
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

3.  Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal.

Authors:  S Borg; H Kvande; U Rydberg; L Terenius; A Wahlström
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 4.  Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling.

Authors:  O S Jørgensen
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.